Saponins from Chinese Buckeye Seed Reduce Cerebral Edema: Metaanalysis of Randomized Controlled Trials

 

 Buy Article Permissions and Reprints

Abstract

To evaluate the effects of saponins from Chinese Buckeye Seed in the treatment of cerebral edema in patients with stroke or cerebral trauma, a metaanalysis of randomized controlled trials was conducted. Randomized trials that compare the effects of treatment with saponins from Chinese Buckeye Seed to placebo treatment, to lack of treatment, to non-specific treatment, or to mannitol treatment for cerebral edema were identified with electronic and manual searches. No blinding and language limitations were applied. The methodological quality of trials was assessed with the Jadad scale plus allocation concealment. The metaanalysis was performed where data were available. Forty-one randomized controlled trials involving 4066 patients were identified. The methodological quality of the trials was generally low. The combined results showed that intravenous administration of saponins from Chinese Buckeye Seed increased the total effective rate, reduced the mortality and the incidence of renal function impairment in comparison to control treatment. No serious adverse event was reported. Based on the metaanalysis, saponins from Chinese Buckeye Seed can reduce cerebral edema in patients with stroke or cerebral trauma. However, the evidence is not sufficient due to the generally low methodological quality of the studies. Further trials are needed with sufficiently numerous group size and rigorous design.

References

• 1 Bingaman W E, Frank J I. Malignant cerebral edema and intracranial hypertension.  Neurol Clin. 1995;  13 479-509
  PubMedGoogle Scholar
• 2 Lang E W, Chesnut R M. Intracranial pressure. Monitoring and management.  Neurosurg Clin N Am. 1994;  5 573-605
  PubMedGoogle Scholar
• 3 Georgiadis A L, Suarez J I. Hypertonic saline for cerebral edema.  Curr Neurol Neurosci Rep. 2003;  3 524-30
  CrossrefPubMedGoogle Scholar
• 4 The Pharmacopoeia Commission of P RC. Pharamacopoeia of the People’s Republic of China, (English edition 1997). Beijin; Chemical Industry Press 1997 Vol. I: p 207
  Google Scholar
• 5 Wei F, Ma L Y, Jin W T, Ma S C, Han G Z, Khan I A, Lin R C. Anti-inflammatory triterpenoid saponins from the seeds of Aesculus chinensis .  Chem Pharm Bull (Tokyo). 2004;  52 1246-8
  CrossrefPubMedGoogle Scholar
• 6 Jadad A R, Moore R A, Carroll D, Jenkinson C, Reynolds D J, Gavaghan D J. et al . Assessing the quality of reports of randomized clinical trials: is blinding necessary?.  Control Clin Trials. 1996;  17 1-12
  CrossrefPubMedGoogle Scholar
• 7 Zheng C J. Beta-escin for cerebral hemorrhage in 42 patients [in Chinese].  Henan J Pract Nerv Dis. 2003;  6 77-8
  PubMedGoogle Scholar
• 8 Zhang C Y, Wen Z M, Bao S Y. Beta-escin for acute cerebral hemorrhage in 123 patients [in Chinese].  Suzhou Univ J Med Sci. 2003;  23 346-8
  PubMedGoogle Scholar
• 9 He Q L, Zhang Y, Dai Y N, Huang G Q, Zhang X X, Guo H S. Beta-escin for acute cerebral infarction [in Chinese].  J Guangdong Med Coll. 2003;  21 157-9
  PubMedGoogle Scholar
• 10 Yang Z. Beta-escin with mannitol for cerebral hemorrhage [in Chinese].  Henan J Pract Nerv Dis. 2003;  6 85
  PubMedGoogle Scholar
• 11 Song Y X. Beta-escin with mannitol for cerebral hemorrhage in 40 patients [in Chinese].  J Diffic Compl Cas. 2002;  1 230-1
  PubMedGoogle Scholar
• 12 Pan G Q, Fang Q, Xu L Z. Beta-escin for cerebral hemorrhage [in Chinese].  Chin J Hemorh. 2002;  12 313-4
  PubMedGoogle Scholar
• 13 Zhu T, Zheng Y. Beta-escin with mannitol for cerebral hemorrhage [in Chinese].  Henan J Pract Nerv Dis. 2002;  5 53-4
  PubMedGoogle Scholar
• 14 Chen Z D, Shen H P. Beta-escin with mannitol for cerebral hemorrhage [in Chinese].  Zhejiang Clin Med J. 2002;  4 668
  PubMedGoogle Scholar
• 15 Gao S S, Ma J W. Beta-escin with mannitol for stroke [in Chinese].  Clin Med J China. 2002;  9 311-2
  PubMedGoogle Scholar
• 16 Qiu Y Z. Beta-escin for cerebral infarction [in Chinese].  China J Mod Med. 2002;  12 73-5
  PubMedGoogle Scholar
• 17 Wen D S, Qiu R, Yao S J. Beta-escin for cerebral infarction in early rehabilitation [in Chinese].  Clin Focus. 2002;  17 128-9
  PubMedGoogle Scholar
• 18 Tang J W. Analysis of beta-escin for cerebral hemorrhage [in Chinese].  J Med Theor Prac. 2002;  15 30-1
  PubMedGoogle Scholar
• 19 Wang Y F, Lang Y M. Beta-escin for cerebral trauma [in Chinese].  Chin JMAP. 2001;  18 496
  PubMedGoogle Scholar
• 20 Ni Z Q, Han J G, Jia X L. Beta-escin for extensive cerebral trauma in 60 patients [in Chinese].  J Hunan Coll TCM. 2001;  21 51-2
  PubMedGoogle Scholar
• 21 Peng W Z, Zhang X C, Yang K Z, Qin Z H. Beta-escin with defibrase for cerebral infarction in old patients [in Chinese].  Youjiang Med J. 2001;  29 186
  PubMedGoogle Scholar
• 22 Cheng G Z. Beta-escin with mannitol for cerebral hemorrhage [in Chinese].  J Brain Nerv Dis. 2001;  9 179
  PubMedGoogle Scholar
• 23 Jin W. Beta-escin for cerebral hemorrhage in 50 patients [in Chinese].  China Contemp Med. 2001;  7 76-7
  PubMedGoogle Scholar
• 24 Li F, Gu D X, Lv X J, Shi J M. Effect of beta-aescin in natrum on cerebral blood flow in patients with cerebral hemorrhage induced by hypertension [in Chinese].  Chin J Integr Tradit West Med Intensive Crit Care. 2001;  8 116-7
  PubMedGoogle Scholar
• 25 Hua M J, Zhou H T, Zhang M D. Discussion of beta-aescinum sodium for the treatment of acute cerebrovascular disease [in Chinese].  Mod Diagn Treat. 2000;  11 321-2
  PubMedGoogle Scholar
• 26 Yang G Q, Duan Z, Chen X L, Zhang X H. Comparison of beta-aescine sodium, mannitol and DXM in treating traumatic encephaledema [in Chinese].  Chin J Med Writing. 2000;  7 1958-60
  PubMedGoogle Scholar
• 27 Chen J H. Beta-escin with mannitol for cerebral edema in patients with cerebral trauma [in Chinese].  Nanjing Troops Med. 2000;  2 37-8
  PubMedGoogle Scholar
• 28 Meng Q F. Beta-escin for cerebral hemorrhage in 68 patients [in Chinese].  Herald Med. 2000;  19 350
  PubMedGoogle Scholar
• 29 Liu P C, Wang P. Beta-escin for cerebral edema in 50 patients [in Chinese].  Chin J Inf Tradit Chin Med. 1999;  6 62
  PubMedGoogle Scholar
• 30 Wang L, Huang D, Li C X. Beta-escin with mannitol for cerebral hemorrhage in 28 patients [in Chinese].  Cent Plains Med J. 1999;  26 13-4
  PubMedGoogle Scholar
• 31 Hu Z C, Sheng X B, Lu A M. ILIB with beta-escin for cerebral infarction in 37 patients [in Chinese].  Shandong Med J. 1999;  39 45
  PubMedGoogle Scholar
• 32 Li Z Y, Wang S Y, Gu T B. Beta-escin for cerebral hemorrhage in 30 patients [in Chinese].  Henan J Pract Nerv Dis. 1999;  2 42
  PubMedGoogle Scholar
• 33 Zhang J S, Shi S P, Cui X C. Beta-escin for cerebral infarction in the early period [in Chinese].  Chin Med Technol. 1999;  6 267
  PubMedGoogle Scholar
• 34 Chen L X, Zhang Y J. Beta-escin for acute cerebral infarction in 65 patients [in Chinese].  Chin J Rural Med pharm. 1999;  6 9-10
  PubMedGoogle Scholar
• 35 Luo Y. Observation of Beta-escin with mannitol for acute cerebral infarction in the near future [in Chinese].  Clin Focus. 1999;  14 612-3
  PubMedGoogle Scholar
• 36 Qu L X, Wang X Q, Su S H. Beta-escin for cerebral hemorrhage [in Chinese].  J Pract Med Tech. 1999;  6 102
  PubMedGoogle Scholar
• 37 Zhang X P, Xie A M. Observation of curative effect of beta-escin combined with mannitol on cerebrovascular disease [in Chinese].  J Taishan Med Coll. 1998;  19 209-12
  PubMedGoogle Scholar
• 38 Lian M Z, Hong Q X, Zhang S X. Beta-escin with low molecular dextran for cerebral infarction [in Chinese].  Strait Pharm J. 1997;  9 89-90
  PubMedGoogle Scholar
• 39 Li F, Gu D X, Cao Z Z, Zhang R Q, Zhu R R. Aescine in treatment of cerebral hemorrhage [in Chinese].  Chin J New Drugs Clin Remedies. 1998;  17 75-7
  PubMedGoogle Scholar
• 40 Gao H J, Geng W J, Liu J. Beta-escin for developing cerebral infarction [in Chinese].  Pract J Rural Doct. 1998;  5 20
  PubMedGoogle Scholar
• 41 He S Q. Beta-escin for stroke in 108 patients [in Chinese].  Mine Factory Med. 1997;  13 195-6
  PubMedGoogle Scholar
• 42 Wang A T, Jia H X, Hao X Z. Beta-escin with mannitol for cerebral hemorrhage in 36 patients [in Chinese].  Pract J Card Cereb Pneumal Vasc Dis. 1997;  5 47-8
  PubMedGoogle Scholar
• 43 Gu D X, Li F, Zhang R Q, Lv X J, Shi J M. Effect of beta-escin and composite Salvia milthiorrhiza on cerebral blood flow, blood haemorrheology and platelet function of patients with cerebral infarction [in Chinese].  Integr Tradit Chin West Med Pract Crit Care Med. 1997;  4 508-10
  PubMedGoogle Scholar
• 44 Zheng Q. Beta-escin with mannitol for stroke in 131 patients [in Chinese].  Chin J Hosp Pharm. 1994;  14 352-3
  PubMedGoogle Scholar
• 45 Li Q F, Yang X J, Yang R L, Yang  X P. Clinical observation of beta-escin and in treatment of intracerebral hemorrhage [in Chinese].  Med Forum J. 2003;  24 18-9
  PubMedGoogle Scholar
• 46 Xu S Z, Kong X M, Li J, Zhu J. Beta-escin with mannitol for acute stroke in 120 patients [in Chinese].  Chin J Tradit West Med. 2003;  4 1518
  PubMedGoogle Scholar
• 47 Miao Z H, Wang G H. Beta-escin for cerebral trauma [in Chinese].  Cent Plains Med J. 2004;  31 47-8
  PubMedGoogle Scholar
• 48 Dickersin K, Min Y I, Meinert C L. Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards.  J Am Med Assoc. 1992;  267 374-8
  CrossrefPubMedGoogle Scholar
• 49 Gorini S, Caponi R. Evaluation of the pharmacological action of escin in experimental cerebral edema produced by craniotomy.  Minerva Neurochir. 1967;  11 357-9
  PubMedGoogle Scholar
• 50 Heppner F, Ascher W P, Argyropoulus G. Current observations on the effect of aescin in neurosurgery.  Wien Med Wochenschr. 1967;  117 706-9
  PubMedGoogle Scholar
• 51 Put T R. Advances in the conservative treatment of acute traumatic cerebral edema. Controlled clinical trial with follow-up examination.  Munch Med Wochenschr. 1979;  121 1019-22
  PubMedGoogle Scholar
• 52 Diemath H E. Treatment and follow-up treatment in head injuries.  Wien Klin Wochenschr Suppl. 1981;  131 1-8
  PubMedGoogle Scholar
• 53 Hu X M, Zhang Y, Zeng F D. Effects of sodium beta-aescin on expression of adhesion molecules and migration of neutrophils after middle cerebral artery occlusion in rats.  Acta Pharmacol Sin. 2004;  25 869-75
  PubMedGoogle Scholar

Prof. Xiaoting Wu

Department of Surgery

West China Hospital

Sichuan University

37 Guo Xue Rd.

Chengdu 610041

Sichuan Province

People’s Republic of China

Phone: +86-28-8542-3411

Fax: 86-28-8542-2411

Email: nutritioner@hotmail.com

• Supplementary Material